Metlife Inc. buy UBS Group AG
Summary
This prediction is currently active. With a performance of 4.84%, the BUY prediction by UBS_Group_AG for Metlife Inc. is trending in the right direction. A total of €0.48 was paid as dividends for this prediction. This prediction currently runs until 10.01.25. The prediction end date can be changed by UBS_Group_AG at any time. UBS_Group_AG has 50% into this predictionMetLife Inc. (Symbol: MET) (WKN: 934623) is a globally renowned insurance, annuities, and employee benefits company, founded in 1868, with its headquarters in New York City. As a leading player in the financial services sector, this Fortune 500 company offers a comprehensive range of products and services, including life insurance, dental and vision coverage, accident and health insurance, retirement and savings solutions, and more. Boasting a diverse clientele, MetLife serves individual customers, SMEs, and large-scale corporations across the globe, with a strong focus on enhancing value for its shareholders, policyholders, and clients. With an underlying commitment to innovation and customer-centric strategies, this publicly traded company (NYSA: MET) has established its presence in more than 40 countries, continuing to expand its horizons in the changing dynamics of global demographics and financial security needs.
Performance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Metlife Inc. | -1.393% | -1.393% |
| iShares Core DAX® | 2.594% | -1.158% |
| iShares Nasdaq 100 | 3.553% | -1.727% |
| iShares Nikkei 225® | 0.687% | -8.354% |
| iShares S&P 500 | 2.209% | -0.942% |
Comments by UBS_Group_AG for this prediction
In the thread Metlife Inc. diskutieren